Acute myeloid leukemia: focus on novel therapeutic strategies. - Test2 - elhamkhani - TriplyDB

Acute myeloid leukemia: focus on novel therapeutic strategies.

Acute myeloid leukemia: focus on novel therapeutic strategies.

http://www.wikidata.org/entity/Q38015336

about

Increased 14-3-3ζ expression in the multidrug-resistant leukemia cell line HL-60/VCR as compared to the parental line mediates cell growth and apoptosis in part through modification of gene expression Association of ABCB1 polymorphisms with prognostic outcomes of anthracycline and cytarabine in Chinese patients with acute myeloid leukemia.All-trans retinoic acid synergizes with topotecan to suppress AML cells via promoting RARα-mediated DNA damage A novel approach for the identification of efficient combination therapies in primary human acute myeloid leukemia specimens.An extensive pharmacokinetic, metabolic and toxicological review of elderly patients under intensive chemotherapy for acute myeloid leukemia.Successful management of acute myeloid leukemia transformed from chronic myelomonocytic leukemia in the elderly by a combination regimen of decitabine and cytarabine, aclarubicin and granulocyte colony-stimulating factor: A case report.Benznidazole modulates cell proliferation in acute leukemia cells.The importance of FLT3 mutational analysis in acute myeloid leukemia.An open-label, single-dose, phase 1 study of the absorption, metabolism and excretion of quizartinib, a highly selective and potent FLT3 tyrosine kinase inhibitor, in healthy male subjects, for the treatment of acute myeloid leukemia.F14512, a polyamine-vectorized anti-cancer drug, currently in clinical trials exhibits a marked preclinical anti-leukemic activity.Association of nitric oxide synthase 3 (NOS3) 894 G>T polymorphism with prognostic outcomes of anthracycline in Chinese patients with acute myeloid leukaemia.

P2860

Q28235429-8BC68ADD-279F-4517-904C-2C0DA48B26C3 Q35539493-8D073C3F-2E5C-43E0-B30F-BDC959739B6A Q35884399-3A31D3AF-D2B6-4C62-B297-D0158695DEB9 Q36283942-395373D5-0C78-4CAB-BA53-036F63AA3920 Q38285621-F8558B70-286F-4E53-B936-07FB18FF79F4 Q40170336-DC18B56A-E414-4407-8EDA-C83FCBD62B32 Q45071683-5F719B52-E735-433B-A2DD-81889C21E62B Q48255430-4E174D56-CAE3-40A0-803C-91749BA78CE3 Q53587222-56C37BAE-E586-4775-8818-974E7028D93E Q54264719-07A929D8-6C67-4D86-ADFC-71424A416BBD Q54363661-86032AC0-8E0B-41AC-BBE8-A3D2E41F27CC

P2860

Acute myeloid leukemia: focus on novel therapeutic strategies.

http://www.wikidata.org/entity/Q38015336

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Acute myeloid leukemia: focus on novel therapeutic strategies.

@en

type

label

Acute myeloid leukemia: focus on novel therapeutic strategies.

@en

prefLabel

Acute myeloid leukemia: focus on novel therapeutic strategies.

@en

P1433

Q38015336-19424365-9097-4AE8-93FF-79801881B92D

P1476

Q38015336-C2939964-200C-4929-AECB-F8A377772F7A

P2093

Q38015336-1336C145-A5F9-4218-BC10-F73723F1F227

P2860

Q38015336-0568535E-561A-4BD7-8866-0B8B993A19DC

Q38015336-0637B5FB-CCC2-4AF1-97E4-CCEE56F155F0

Q38015336-06E68F74-62EE-43C8-A787-8C0462A9781F

Q38015336-07AF5E02-6582-4E28-8E3B-0237A4DCB5E7

Q38015336-081736B4-8FB4-4888-85C3-D7C1E9815A99

Q38015336-0CDC4881-EB95-4056-B688-215485428C1C

Q38015336-0D8131F5-3FD0-4FF9-B26A-9281FB27A1DD

Q38015336-1626A329-F923-4286-B7D4-6138745A5673

Q38015336-16370778-F4A3-4ADA-B917-DE2DE55C45CA

Q38015336-173DA998-910B-46D1-BA7A-F722D9594695

P304

Q38015336-8A8D8E31-384F-49DE-8022-386EF69EB239

P31

Q38015336-8133D797-B02A-4190-A86A-7E00E52A58F5

P356

Q38015336-033AF0A2-927C-498D-943F-0A8EA623FE57

P407

Q38015336-497B72A7-5875-474D-A44C-7CE3959D56F6

P478

Q38015336-0C9F4322-6732-4A77-9C50-CF8723B71584

P50

Q38015336-A857E740-7038-49CF-8D6B-C2E16589B176

P577

Q38015336-F2CF135F-AA50-4A11-A668-54BE2A0E537C

P5875

Q38015336-F9A468D6-B7B1-4DE6-A7ED-3207D492325E

P698

Q38015336-386BFC16-F18F-4651-A37D-8B9C50C1D417

P932

Q38015336-391A40E7-03A9-4016-BEE3-83C47A1A92C7

P356

P1433

Clinical Medicine: Oncology

P1476

Acute myeloid leukemia: focus on novel therapeutic strategies

@en

P2093

M Yair Levy

http://www.w3.org/2001/XMLSchema#string

P2860

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations.

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study

The Hedgehog and Wnt signalling pathways in cancer

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

P304

205-217

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4137/CMO.S7244

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225086747

http://www.w3.org/2001/XMLSchema#string

P698

22654526

http://www.w3.org/2001/XMLSchema#string

P932

3362331

http://www.w3.org/2001/XMLSchema#string